Research //

Approval for new trial to prevent Group B Strep in newborn babies

Health Minister Nadine Dorries has announced today (Friday 1 Novermber 2019) that the Group B Strep trial has been given ethical approval by the Health Research Authority in England and Health and Care Research in Wales.

Group B Strep is the most common cause of life-threatening infection in newborn babies, causing a range of serious infections including pneumonia, meningitis and sepsis.

Continue Reading

To access this content please register.

Register for Free

Already a member? Login

Please register or login to comment!

Register now Login

Select a page to copy this section to:

Select where in the level you want it inserted: